Simultaneous Bilateral Video–Endoscopic Inguinal Lymphadenectomy for Penile Carcinoma: Surgical Setting, Feasibility, Safety, and Preliminary Oncological Outcomes

Author:

Gaya Josep M.1,Basile Giuseppe12,Gavrilov Pavel1,Gallioli Andrea1,Territo Angelo1,Robalino Jorge1,Hernandez Pedro1,Sanchez-Molina Raul1,Bravo Alejandra1,Algaba Ferran3,Huguet Jordi1,Sanguedolce Francesco14ORCID,Palou Joan1ORCID,Rosales Antonio1,Breda Alberto1

Affiliation:

1. Department of Urology, Fundació Puigvert, Autonomous University of Barcelona, 08025 Barcelona, Spain

2. Department of Urology, Vita-Salute San Raffaele University, 08025 Milan, Italy

3. Department of Pathology, Fundació Puigvert, Autonomous University of Barcelona, 08025 Barcelona, Spain

4. Department of Medicine, Surgery and Pharmacy, Sassari University, 07100 Sassari, Italy

Abstract

Introduction: Inguinal lymph node dissection (ILND) plays an important role for both staging and treatment purposes in patients diagnosed with penile carcinoma (PeCa). Video–endoscopic inguinal lymphadenectomy (VEIL) has been introduced to reduce complications, and in those patients elected for bilateral ILND, a simultaneous bilateral VEIL (sB-VEIL) has also been proposed. This study aimed to investigate the feasibility, safety, and preliminary oncological outcomes of sB-VEIL compared to consecutive bilateral VEIL (cB-VEIL). Material and methods: Clinical N0-2 patients diagnosed with PeCa and treated with cB-VEIL and sB-VEIL between 2015 and 2023 at our institution were included. Modified ILND was performed in cN0 patients, while cN+ patients underwent a radical approach. Intra- and postoperative complications, operative time, time of drainage maintenance, length of hospital stay and readmission within 90 days, as well as lymph node yield, were compared between the two groups. Results: Overall, 30 patients were submitted to B-VEIL. Of these, 20 and 10 patients underwent cB-VEIL and sB-VEIL, respectively. Overall, 16 (80%) and 7 (70%) patients were submitted to radical ILND due to cN1-2 disease in the cB-VEIL and sB-VEIL groups, respectively. No statistically significant difference emerged in terms of median nodal yield (13.5 vs. 14, p = 0.7) and median positive LNs (p = 0.9). sD-VEIL was associated with a shorter operative time (170 vs. 240 min, p < 0.01). No statistically significant difference emerged in terms of intraoperative estimated blood loss, length of hospital stay, time to drainage tube removal, major complications, and hospital readmission in the cB-VEIL and sB-VEIL groups, respectively (all p > 0.05). Conclusions: Simultaneous bilateral VEIL is a feasible and safe technique in patients with PeCA, showing similar oncological results and shorter operative time compared to a consecutive bilateral approach. Patients with higher preoperative comorbidity burden or anesthesiological risk are those who may benefit the most from this technique.

Publisher

MDPI AG

Subject

General Medicine

Reference24 articles.

1. Ayres, B., Crook, J., van der Heijden, M., Johnstone, P., Necchi, A., Oliveira, P., Spiess, P.E., Johnstone, P.A.S., Crook, J., and Pettaway, C.A. (2023). EAU-ASCO Collaborative Guidelines on 2023, American Society of Clinical Oncology Publications.

2. Anatomic considerations of the penis, lymphatic drainage, and biopsy of the sentinel node;Wood;Urol. Clin. N. Am.,2010

3. Usage and survival implications of surgical staging of inguinal lymph nodes in intermediate- to high-risk, clinical localized penile cancer: A propensity-score matched analysis;Woldu;Urol. Oncol.,2018

4. Diagnostic Accuracy of Dynamic Sentinel Lymph Node Biopsy for Penile Cancer: A Systematic Review and Meta-analysis;Fallara;Eur. Urol. Focus,2023

5. Update in the surgical principles and therapeutic outcomes of inguinal lymph node dissection for penile cancer;Ercole;Urol. Oncol.,2013

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3